These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20505842)

  • 21. Behavioral phenotype in adults with Prader-Willi syndrome.
    Sinnema M; Einfeld SL; Schrander-Stumpel CT; Maaskant MA; Boer H; Curfs LM
    Res Dev Disabil; 2011; 32(2):604-12. PubMed ID: 21227640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data.
    Peleggi A; Bohonowych J; Strong TV; Schwartz L; Kim SJ
    BMC Psychiatry; 2021 Sep; 21(1):438. PubMed ID: 34488710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
    State MW; Dykens EM; Rosner B; Martin A; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):329-34. PubMed ID: 10087695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C; Tauber M
    J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressive and receptive language in Prader-Willi syndrome: report on genetic subtype differences.
    Dimitropoulos A; Ferranti A; Lemler M
    J Commun Disord; 2013; 46(2):193-201. PubMed ID: 23295077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader-Willi syndrome.
    Wang TS; Tsai WH; Tsai LP; Wong SB
    Ci Ji Yi Xue Za Zhi; 2020; 32(2):137-144. PubMed ID: 32269945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavior and personality characteristics of children and young adults with Prader-Willi syndrome: a controlled study.
    Akefeldt A; Gillberg C
    J Am Acad Child Adolesc Psychiatry; 1999 Jun; 38(6):761-9. PubMed ID: 10361796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models for Prader-Willi syndrome.
    Zahova S; Isles AR
    Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural change in Prader-Willi syndrome during COVID-19 pandemic.
    Wieting J; Eberlein C; Bleich S; Frieling H; Deest M
    J Intellect Disabil Res; 2021 Jul; 65(7):609-616. PubMed ID: 33754414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
    Butler MG; Miller JL; Forster JL
    Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome.
    Holland AJ; Whittington JE; Butler J; Webb T; Boer H; Clarke D
    Psychol Med; 2003 Jan; 33(1):141-53. PubMed ID: 12537045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
    Bonnot O; Cohen D; Thuilleaux D; Consoli A; Cabal S; Tauber M
    Eur J Pediatr; 2016 Jan; 175(1):9-18. PubMed ID: 26584571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls.
    Kim JW; Yoo HJ; Cho SC; Hong KE; Kim BN
    J Child Neurol; 2005 Feb; 20(2):134-8. PubMed ID: 15794180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological, Behavioral, and Ethical Considerations of Prader-Willi Syndrome: A Primer for Behavior Analysts.
    Kennedy D; Marten H; O'Sullivan C; Catrone R
    Behav Anal Pract; 2022 Jun; 15(2):562-570. PubMed ID: 35692531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring patterns of unwanted behaviours in adults with Prader-Willi syndrome.
    Pignatti R; Mori I; Bertella L; Grugni G; Giardino D; Molinari E
    J Appl Res Intellect Disabil; 2013 Nov; 26(6):568-77. PubMed ID: 23613474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.
    Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP
    J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.
    Dykens EM; Miller J; Angulo M; Roof E; Reidy M; Hatoum HT; Willey R; Bolton G; Korner P
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.